Cleared Special

Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Strip, Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Cassette, Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Midstream (K213808) - FDA 510(k) Clearance

Class II Chemistry device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K213808 · Co-Innovation Biotech Co., Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
120d
Days
Class 2
Risk

K213808 is an FDA 510(k) clearance for the Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Strip, Co-Inno.... Classified as Kit, Test, Pregnancy, Hcg, Over The Counter (product code LCX), Class II - Special Controls.

Submitted by Co-Innovation Biotech Co., Ltd. (Guangzhou, CN). The FDA issued a Cleared decision on April 5, 2022 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Co-Innovation Biotech Co., Ltd. devices

Submission Details

510(k) Number K213808 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 2021
Decision Date April 05, 2022
Days to Decision 120 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 88d · This submission: 120d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LCX Kit, Test, Pregnancy, Hcg, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LCX Kit, Test, Pregnancy, Hcg, Over The Counter

All 49
Devices cleared under the same product code (LCX) and FDA review panel - the closest regulatory comparables to K213808.
MissLan™ Digital Pregnancy Rapid Test
K222305 · Guangzhou Decheng Biotechnology Co., Ltd. · Nov 2022
Clearblue ® Early Pregnancy Test
K213379 · Spd Swiss Precision Diagnostics GmbH · Sep 2022
hCG One Step Pregnancy Test
K212418 · Healstone Biotech, Inc. · Jun 2022
One Step Pregnancy Test
K210341 · Spd Swiss Precision Diagnostics GmbH · Mar 2022
SEJOY hCG One Step Pregnancy Test Strip, SEJOY hCG One Step Pregnancy Test Cassette, SEJOY hCG One Step Pregnancy Test Midstream
K212447 · Hangzhou Sejoy Electronics & Instruments Co., Ltd. · Feb 2022
Clearblue® Early Digital Pregnancy Test
K200913 · Spd Swiss Precision Diagnostics GmbH · Aug 2021